• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Foghorn Therapeutics Inc.

    10/8/24 5:44:34 PM ET
    $FHTX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $FHTX alert in real time by email
    SC 13G/A 1 s13ga_100724-foghorn.htm

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    SCHEDULE 13G
    (Rule 13d-102)
     
    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
    TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
    PURSUANT TO RULE 13d-2
    (Amendment No. 1) *
     
     
    Foghorn Therapeutics Inc.
    (Name of Issuer)
     
     
    Common Stock, $0.0001 par value
    (Title of Class of Securities)
     
    344174107
    (CUSIP Number)
     
     
    September 30, 2024
    (Date of Event Which Requires Filing of this Statement)

     

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    [ ] Rule 13d-1(b)

     

    [ ] Rule 13d-1(c)

     

    [X] Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

     
     

     

     

    1. 

     

    NAME OF REPORTING PERSON

     

    The Klarman Family Foundation

     

     

    2. 

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) [ ]

    (b) [ ]

     

    3. 

     

    SEC USE ONLY

     

    4. 

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Massachusetts

     

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH

     

    5. 

     

    SOLE VOTING POWER

    0

    6. 

     

    SHARED VOTING POWER

    2,139,639

    7. 

     

    SOLE DISPOSITIVE POWER

    0

    8. 

     

    SHARED DISPOSITIVE POWER

    2,139,639

     

    9. 

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON

    2,139,639

    10. 

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES [_]

    CERTAIN SHARES

     

    11. 

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    3.9% (1)

     

    12. 

     

    TYPE OF REPORTING PERSON

    OO

           

    (1) Based on 55,328,655 shares of Common Stock outstanding as of July 31, 2024, as reported in the Issuer’s Report on Form 10-Q for the period ended June 30, 2024 filed with the Securities and Exchange Commission on August 8, 2024.

     
     

     

     

     

    1. 

     

    NAME OF REPORTING PERSON

     

    Seth A. Klarman

     

     

    2. 

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) [ ]

    (b) [ ]

     

    3. 

     

    SEC USE ONLY

     

    4. 

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

     

     

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH

     

    5. 

     

    SOLE VOTING POWER

    0

    6. 

     

    SHARED VOTING POWER

    2,139,639 (1)

    7. 

     

    SOLE DISPOSITIVE POWER

    0

    8. 

     

    SHARED DISPOSITIVE POWER

    2,139,639 (1)

     

    9. 

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON

    2,139,639 (1)

    10. 

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES [_]

    CERTAIN SHARES

     

    11. 

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    3.9% (2)

     

    12. 

     

    TYPE OF REPORTING PERSON

    IN, HC

           

    (1) Represents shares held by The Klarman Family Foundation. Mr. Klarman may be deemed to share beneficial ownership of such shares within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, however he has no pecuniary interest therein.

    (2) Based on 55,328,655 shares of Common Stock outstanding as of July 31, 2024, as reported in the Issuer’s Report on Form 10-Q for the period ended June 30, 2024 filed with the Securities and Exchange Commission on August 8, 2024.

     
     

     

    AMENDMENT NO. 1 TO SCHEDULE 13G (FINAL AMENDMENT)

     

    Reference is hereby made to the statement on Schedule 13G filed with the Securities and Exchange Commission by the Reporting Persons with respect to the Common Stock of the Issuer on February 4, 2021 (the “Schedule 13G”). Terms defined in the Schedule 13G are used herein as so defined.

     

    The following Items of the Schedule 13G are hereby amended and restated as follows:

     

    Item 4. Ownership

    (a) through (c):

    The information requested in these paragraphs is incorporated by reference to the cover pages to this Amendment No. 1 to Schedule 13G.

     

    Item 5. Ownership of Five Percent or Less of the Class

     

    If this statement is being filed to report the fact that the Reporting Persons have ceased to be the beneficial owners of more than five percent of the Common Stock, check the following: [X]

     
     

    SIGNATURES

     

    After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certify that the information set forth in this Statement is true, complete and correct.

     

    Dated: October 8, 2024

     

    THE KLARMAN FAMILY FOUNDATION

    By: KFO, LLC, its investment manager

     

     

    By: _/s/ David P. Berkowitz______

    Name: David P. Berkowitz

    Title: Chief Investment Officer

     

    SETH A. KLARMAN

     

    _/s/ Seth A. Klarman___________

    Seth A. Klarman, individually

     

    Get the next $FHTX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FHTX

    DatePrice TargetRatingAnalyst
    4/23/2025$9.00Mkt Outperform
    Citizens JMP
    1/30/2025$10.00Buy
    B. Riley Securities
    9/3/2024$18.00Buy
    Jefferies
    8/19/2024$20.00Outperform
    Evercore ISI
    3/28/2023$10.00Buy
    BofA Securities
    1/5/2023$20.00Outperform
    BMO Capital Markets
    12/15/2021$23.00 → $26.00Overweight
    Morgan Stanley
    11/22/2021$25.00Buy
    HC Wainwright & Co.
    More analyst ratings